ProVen Health VCT, managed by Beringea LLP, has sold its investment in Onyx Scientific in a transaction that valued the company at GBP4.6m.   Onyx Scientific provides a wide range of chemical services to the life sciences industry. In particular, its key focus is scaling up the synthesis of new chemical entities from micrograms to kilograms for pharmaceutical companies. Onyx specialises in medicinal chemistry, pre-clinical development and GMP scale-up, in addition to offering a comprehensive range of analytical services. ProVen Health VCT invested GBP750,000 in Onyx in June 2007. Onyx was acquired by ICPA, a market leader in anti-malarial and

Krokus Private Equity has signed an agreement to acquire 75% of the shares in Termo-Organika Sp. z o.o. Krokus PE has made this investment together with the Management of the Company in buyout from the international construction material group CRH plc. Termo-Organika is Poland’s leading producer of wide range of housing insulation products made of polystyrene foam. The Company also sells a range of branded complementary products like adhesives, plasters, mortars, paints in its ‘Platinum insulation system’ as well as other products (e.g. XPS). Termo-Organika insulation systems are used for facades, roofs & floors, foundations etc. The company is the

Investcorp, a global provider and manager of alternative investment products, has acquired Sur La Table, a leading national kitchenware retailer with locations across the United States.  The terms of the transaction have not been disclosed. Sur La Table was acquired from the Behnke family and investment firm Freeman Spogli & Co. who will both remain as investors in the company. With its headquarters in Seattle, WA, Sur La Table is a multi-channel retailer that sells through 86 stores in the United States, as well as through its catalog, website and gift registry.  It offers a broad selection of kitchenware brands

ActivePath, developer of ActiveMail Interactive Email and Messaging solutions, has secured a USD10 million financing round led by Battery Ventures and Gimv NV, with participation from existing investors including Genesis Partners.   ActivePath will deploy the capital to accelerate product development and drive sales and marketing penetration in the Americas and Europe. In connection with the funding, Scott Tobin, General Partner at Battery Ventures, and Steven Coppens, partner at Gimv’s Venture Capital team, will join ActivePath’s Board of Directors. “Email marketing is an enormously huge and rapidly growing market that’s on the cusp of a major transformation. Whether it’s commercial

Steadfast Capital has achieved a first close of its third fund at EUR104 million in just four months.   Support from existing investors Electra, Axa and F&C combined with the addition of some well regarded new institutions including EIF, Goldman Sachs, IdInvest, Graphite and Swiss Re enabled the fund, which launched early this year with a final target of EUR250 million, to reach this important milestone. Steadfast Capital’s ongoing commitment to its proven investment strategy, which has been undertaken successfully for preceding funds, played a key role in securing investor support. The firm, which specialises in the German mid-market, targets

Cortus has closed a funding round led by financial partners Credit Agricole Entreprises and Banque Dupuy de Parseval and institutional partners OSEO and the Region of Languedoc-Roussillon.

 Since starting in 2005, Cortus has completed the development of an extensive ecosystem for its APS3 core and achieved key design wins in a variety of rapidly growing market segments. The new funding secures the international expansion and development plans over the next three years allowing Cortus to scale their technical and business development activities. Cortus are now accelerating the recruitment of talented individuals for both engineering and sales roles.

 Cortus’ 32 bit